vimarsana.com
Home
Live Updates
Onconova Therapeutics Appoints Drs. Peter Atadja and : vimar
Onconova Therapeutics Appoints Drs. Peter Atadja and : vimar
Onconova Therapeutics Appoints Drs. Peter Atadja and
NEWTOWN, Pa., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company...
Related Keywords
Kumasi ,
Ashanti ,
Ghana ,
China ,
United States ,
United Kingdom ,
London ,
City Of ,
British ,
Trafford Clarke ,
Mark Guerin ,
Stevenm Fruchtman ,
Peter Atadja ,
Bruce Mackle ,
Eli Lilly ,
Kumasi University Of Science ,
Company Contact ,
Sandbox Innovation Fund Program ,
Nasdaq ,
University Of Liverpool ,
Innovation Board Of The Association ,
Novartis Pharmaceuticals ,
Research Directors Group ,
European Union Innovative Medicine Initiative ,
Lifesci Advisors ,
Company Board Of Directors ,
United Kingdom Research ,
Hebrew University ,
Imperial College ,
Drug Discovery Translational Research ,
Development Site Head ,
Company Ltd ,
University Of Calgary ,
Securities Exchange ,
Onconova Therapeutics Inc ,
Eli Lilly European Federation Of Pharmaceutical Industries ,
Chief Executive Officer ,
Chief Scientific Officer ,
Commbio Therapeutics ,
Executive Director ,
Drug Discovery ,
Award Winner ,
Kumasi University ,
Managing Director ,
European Federation ,
Pharmaceutical Industries ,
Union Innovative Medicine Initiative ,
Board Member ,
Innovation Board ,
British Pharmaceutical ,
Innovation Fund ,
Onconova Therapeutics ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Annual Report ,
Sci Advisors ,
Nasdaq Ontx ,
Nc ,
Ntx Onconova Narazaciclib ,
Biotechnology ,
Dk4 6 Ark5 Inhibitor ,
Nsclc ,
Deb Associated Scc ,